Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
sodium chloride (1 trial)
cysteamine (cystagon) (1 trial)
ivacaftor (Kalydeco) (1 trial)
pgm169/gl67a (1 trial)
rpl554 (1 trial)
tezacaftor (Trifakta) (1 trial)
fluticasone (cutivate) (1 trial)
Cystic Fibrosis (Phase 3)
Fibrosis (Phase 3)
Trials (6 total)
Trial APIs (7 total)